[ 4 ] Liver EAFTSOT. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis[J]. J Hepatol, 2010, 53(3): 397-417.
[2]
[ 5 ] Ginès P, Jiménez W. Aquaretic agents: a new potential treatment of dilutional hyponatremia in cirrhosis[J]. J Hepatol, 1996, 24(4): 506-512.
Guevara M, Baccaro ME, Torre A, et al. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis[J]. Am J Gastroenterol, 2009, 104(6): 1382-1389.
[11]
Borroni G, Maggi A, Sangiovanni A, et al. Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients[J]. Dig Liver Dis, 2000, 32(7): 605-610.
[ 2 ] Kim JH, Lee JS, Lee SH, et al. The association between the serum sodium level and the severity of complications in liver cirrhosis[J]. Korean J Intern Med, 2009, 24(2): 106-112.
